Sinovac Biotech, Ltd. SVA
6.47 USD 0.00 (+0.00%)
At closeOct 28, 2026, 4:00 PM EDT
6.47 Day range 6.47
6.47 52-week range 6.47
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 464.94M
- Forward P/E
- -53.92
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Previous close
- 6.47
- Day's range
- 6.47 – 6.47
- 52-week range
- 6.47 – 6.47
- Analysts
- Buy
- Price target
- 3.52 (-45.6%)
2Y 0.00 (0.00%)
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 6.47
- 200-day average
- 6.47
Analyst view
Consensus: buy
Buy
Price target (mean) 3.52 -45.6% downside
Now 6.47
- Target (low)
- 1.50
- Target (mean)
- 3.52
- Target (high)
- 6.00
Next earnings
Consensus EPS estimate -0.03.
Financials — quick view
SVA Revenue — annual 386.01M
SVA Net income — annual -59.68M
SVA EPS — annual -0.83
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 20, 2014 | Morgan Stanley | up | — | Overweight |
| Nov 13, 2013 | Aegis Capital | main | — | Buy |
| Aug 15, 2013 | Aegis Capital | up | Hold | Buy |
| May 15, 2013 | Morgan Stanley | up | Underperform | Equal-Weight |
| Mar 14, 2013 | Aegis Capital | main | — | Hold |
| Dec 12, 2012 | Aegis Capital | init | — | Hold |
News
Sernova, Seraxis Aim for Type 1 Diabetes ‘Functional Cure’ With BetaNova Merger 
SINOVAC Reports Unaudited First Half of 2026 Financial Results 
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend 
SINOVAC Regained Compliance With the Nasdaq Global Market's Listing Requirements 
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F 
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report 
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend 
SINOVAC Reports Unaudited First Half of 2025 Financial Results 
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
Your note
Sign in to keep a note on SVA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOWERING TERRY G | Chief Executive Officer | Sale | Sep 23, 2003 | 0 |
| IFG INVESTMENTS SERVICES INC | Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 3, 2003 | 0 |